LRRC25 and breast carcinoma: The next two strongest signals were for SNPs in moderate LD with rs11668719, namely rs7257932 (r2 = 0.39; p-value: 2.5x10-04), which is the only SNP predicting LRRC25 expression previously implicated in breast cancer GWAS, and rs13344313 (r2 = 0.43; p-value: 3.2x10-03).